Moreno Evelyn V boosted its stake in shares of Novo Nordisk A/S (NYSE:NVO – Free Report) by 169.2% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,740 shares of the company’s stock after purchasing an additional 6,751 shares […]
ST Germain D J Co. Inc. cut its stake in shares of Novo Nordisk A/S (NYSE:NVO – Free Report) by 25.2% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 87,480 shares of the company’s stock after selling 29,424 shares during the quarter. […]
GDS Wealth Management acquired a new position in Novo Nordisk A/S (NYSE:NVO – Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 2,352 shares of the company’s stock, valued at approximately $214,000. Several other hedge funds and other institutional investors have […]
WS Portfolio Advisory LLC acquired a new position in shares of Novo Nordisk A/S (NYSE:NVO – Free Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 42,688 shares of the company’s stock, valued at approximately $3,882,000. A number of other large investors […]
Apeiron RIA LLC grew its stake in Novo Nordisk A/S (NYSE:NVO – Free Report) by 102.5% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,786 shares of the company’s stock after purchasing an additional 2,422 shares during the period. Apeiron […]